Biophore receives sub-license from MPP to manufacture and market molnupiravir for COVID treatment
· Can market in India and 104 other countries
· Has also received DCGI regulatory license for Indian market
· Licenses applicable for both API and finished product
Biophore India...
Biophore to manufacture indigenous ingredients of Pfizer’s COVID drug
· Reduces dependence on China for Indian manufacturers
· Paxlovid approved by US FDA for COVID treatment
Biophore India Pharmaceuticals has today announced that they have developed and...
Aster DM Healthcare to set up its 6th Hospital in Kerala
· Entailing an initial investment of around Rs. 140 crores, the hospital will be situated in the Kasaragod district of Kerala
· Aster aims for the hospital...
Oral cancer surgery with no disability and restoration of normal functions
BGS Gleneagles Global Hospital successfully treats a 52-year- old schoolteacher, suffering from advanced oral cancer. In the month of September 2021, Mr. Nitin (Name...
Glenmark Pharmaceuticals receives ANDA tentative approval for Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL) Single-Dose Pre-Filled Syringe
Glenmark Pharmaceuticals Inc., USA (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Regadenoson Injection, 0.4 mg/5...
Views: 0